Early Decrease of Skin Blood Flow in Response to Locally Applied Pressure in Diabetic Subjects
- Berengere Fromy1,
- Pierre Abraham1,
- Celine Bouvet1,
- Beatrice Bouhanick2,
- Philippe Fressinaud2 and
- Jean Louis Saumet1
- 1Laboratory of Physiology, Medicine Department, University of Angers, Angers, France
- 2Department of Internal Medicine and Diabetology, University Hospital, Angers, France
Abstract
Pressure ulcers are common debilitating complications of diabetes that are caused by tissue ischemia. Skin blood flow in response to locally applied pressure might be impaired in diabetic patients because of the combined effects of a typically low skin temperature and alterations in microcirculatory function, and could be worsened by neuropathy. We measured skin blood flow by laser Doppler flowmetry over the internal anklebone in response to local pressure applied at 5.0 mmHg/min in three groups of diabetic patients (with clinical and subclinical neuropathy and without neuropathy) and in healthy matched control subjects at usual room temperature. Compared with in matched control subjects with comparable skin temperatures (29.3 ± 0.4 vs. 28.7 ± 0.4°C), in diabetic patients the skin blood flow response to locally applied pressure was further impeded, even in those without neuropathy. Indeed, skin blood flow decreased significantly from baseline at much lower applied pressure (7.5 mmHg) in diabetic subjects, again even in those without neuropathy, than in control subjects (48.8 mmHg). The large difference between these pressures could partially explain diabetic patients’ high risk of developing decubitus and plantar ulcers.
Footnotes
-
Address correspondence and reprint requests to Prof. Jean Louis Saumet, Laboratory of Physiology, UPRES EA-2170, Department of Medicine, University of Angers, F-49045 Angers, France. E-mail: jeanlouis.saumet{at}univ-angers.fr.
Received for publication 21 August 2001 and accepted in revised form 8 January 2002.
CGRP, calcitonin gene-related peptide; PIV, pressure-induced vasodilation; TcPO2, transcutaneous oxygen pressure.
- DIABETES














